
Please try another search
Crown Bioscience is a global Contract Research Organization (CRO) headquartered in California, US, that provides discovery, preclinical, and translational platforms and services to advance oncology and immuno-oncology. The company aims to deliver superior drug candidates to ensure that patients receive the right treatment at the right time. Crown Biosciences offers in vitro biology platforms, including 2D cell lines, CRISPR/Cas9, organoids, and high-quality imaging, to enhance oncological drug discovery. The team has extensive experience working with companies to support the pharmacology characterization of lead compounds and provides efficient screening platforms and validated 2D and 3D models to support faster, better decision-making for oncologists' drug discovery programs. Crown's mission is to empower its customers to improve human health by leveraging the world's largest commercial database of well-characterized cell lines for evaluation of novel molecules.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review